Home | Medical-Newswire.Com:
(Medical-NewsWire.com, July 17, 2017 ) Tardive dyskinesia is an involuntary movement disorder that typically arises from the long-term use of antipsychotic medication in schizoaffective disorders. Tardive dyskinesia is characterized by involuntary, repetitive movements of the face, trunk, or extremities, including lip smacking, grimacing, tongue protrusion, facial movements or blinking, puckering and pursing of the lips. TDs are most common in patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have been treated with antipsychotic medication for long periods, but they occasionally occur in other patients as well.
For more information http://www.reportsweb.com/tardive-dyskinesia-market-report-focus-on-us-and-japan-2016-2025
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
The report "Tardive Dyskinesia Market" provides a comprehensive study of the US and Japan tardive dyskinesia market with detailed analysis of market size, growth and penetration of the industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Valeant Pharmaceuticals, Neurocrine Biosciences and Teva Pharmaceuticals Industries Ltd. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001858477/sample
1. Tardive Dyskinesias - An Overview
2. The US Tardive Dyskinesia Market Analysis
3. Japan Tardive Dyskinesia Market Analysis
4. The US Tardive Dyskinesia Drugs Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
7.1 Valeant Pharmaceuticals
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Neurocrine Biosciences
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Teva Pharmaceuticals Industries Ltd.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001858477/buying